D.C. Marketplace encourages labs to remove race from kidney function test to advance equity
The Health Insurance Marketplace for the District of Columbia is encouraging labs to remove race as a variable in the estimated glomerular filtration rate (eGFR) formula commonly used to measure kidney function, as recommended by the National Kidney Foundation and American Society of Nephrology to support health equity. The use of race in the equation for eGFR can exacerbate disparities in health outcomes. The D.C. marketplace, known as DC Health Link, covers 100,000 enrollees and 5,300 employers in all 50 states.
Related News Articles
Headline
Duke University’s Anna Tharakan, lead project manager on Closing the Gap on Hypertension Disparities, and Bradi Granger, Ph.D., research professor at Duke…
Headline
A National Institutes of Health study published April 2 found that blood pressure patterns observed during the first half of pregnancy can determine a woman's…
Headline
A study published March 31 by the National Institutes of Health found that adults living in rural areas have worse cardiovascular health than those in urban…
Headline
The AHA yesterday released its 2025 Advocacy Agenda that details the association's key priorities for Congress, the Administration, regulatory agencies and…
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…
Headline
The AHA’s Institute for Diversity and Health Equity will host its next Health Equity Innovation Summit in Washington, D.C., on Nov. 12 from 9:30 a.m. to 3:30 p…